Post by Genentech

Name: #Breaking: We are excited to share positive results from our Phase III trials evaluating our investi
Uploaded: 2026-04-21T23:19:15.585Z
Channel: Genentech
Description: #Breaking: We are excited to share positive results from our Phase III trials evaluating our investigational BTK inhibitor in people living with relapsing multiple sclerosis (RMS). For the more than

940,112 followers

#Breaking: We are excited to share positive results from our Phase III trials evaluating our investigational BTK inhibitor in people living with relapsing multiple sclerosis (RMS). For the more than 2.9 million people living with multiple sclerosis (MS) worldwide, this data brings our research and development strides into focus, representing a potential new approach to MS with comprehensive disease control. Learn more: http://spr.ly/6046BB8uD8

Video Content